NeueHealth Inc (NEUE) just unveiled an announcement.
NeueHealth, Inc. successfully conducted its 2024 Annual Meeting of Stockholders with a strong attendance, resulting in the election of ten directors to serve until the next annual meeting. Shareholders ratified the appointment of Deloitte & Touche LLP as the firm’s independent auditor for the upcoming fiscal year and approved the executive compensation on an advisory basis. Additionally, the company’s Second Amended and Restated 2021 Omnibus Incentive Plan received shareholder approval.
Find detailed analytics on NEUE stock on TipRanks’ Stock Analysis page.
